Detalhe da pesquisa
1.
Estimation of manufacturing development costs of cell-based therapies: a feasibility study.
Cytotherapy
; 23(8): 730-739, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593688
2.
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.
Cytotherapy
; 22(7): 388-397, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414635
3.
Pragmatic rules for comparability of biological medicinal products.
Biologicals
; 63: 97-100, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836276
4.
Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over in vivo release testing of vaccines.
Expert Rev Vaccines
; 22(1): 369-377, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010241
5.
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines.
Vaccine
; 41(38): 5603-5613, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527955
6.
Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.
Vaccine
; 40(38): 5601-5607, 2022 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999078
7.
Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.
Vaccine
; 39(18): 2506-2516, 2021 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824038
8.
Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines.
Expert Rev Vaccines
; 20(10): 1221-1233, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550041
9.
Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.
Front Med (Lausanne)
; 7: 91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300597
10.
Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].
Vaccine
; 40(23): 3272-3273, 2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469695
11.
Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity.
Vaccine
; 29(32): 5114-21, 2011 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624423
12.
High-level acetaldehyde production in Lactococcus lactis by metabolic engineering.
Appl Environ Microbiol
; 71(2): 1109-13, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15691976
13.
Overproduction of heterologous mannitol 1-phosphatase: a key factor for engineering mannitol production by Lactococcus lactis.
Appl Environ Microbiol
; 71(3): 1507-14, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15746354
14.
Effects of cultivation conditions on folate production by lactic acid bacteria.
Appl Environ Microbiol
; 69(8): 4542-8, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12902240
15.
IS981-mediated adaptive evolution recovers lactate production by ldhB transcription activation in a lactate dehydrogenase-deficient strain of Lactococcus lactis.
J Bacteriol
; 185(15): 4499-507, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12867459
16.
Metabolic engineering of lactic acid bacteria, the combined approach: kinetic modelling, metabolic control and experimental analysis.
Microbiology (Reading)
; 148(Pt 4): 1003-1013, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11932446